Health Products

Sandoz-Irbesartan Product Recall (2021-05-27)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I

Summary

Product

Sandoz Irbesartan 150mg Tablet

Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDIN, NPN, DIN-HIMDosage formStrength
KF8326
Recalling Firm
Sandoz Canada Inc
110 de Lauzon
Boucherville
J4B 1E6
Quebec
CANADA
Marketing Authorization Holder
Sandoz Canada Inc
110 de Lauzon
Boucherville
J4B 1E6
Quebec
CANADA
B. Sandoz Irbesartan 300mg TabletDIN 02328496TabletIrbesartan 300mg 
KC7216
Recalling Firm
Sandoz Canada Inc
110 de Lauzon
Boucherville
J4B 1E6
Quebec
CANADA
Marketing Authorization Holder
Sandoz Canada Inc
110 de Lauzon
Boucherville
J4B 1E6
Quebec
CANADA
A. Sandoz Irbesartan 150mg TabletDIN 02328488TabletIrbesartan 150mg 

Introduction

  1. Sandoz Irbesartan 150mg Tablet

  2. Sandoz Irbesartan 300mg Tablet

Reason

Presence of impurity 5-(4-(azidomethyl)-[1,1-biphenyl]-2-yl)-1H-tetrazole above the acceptable concentration limit in affected lots.

Depth of distribution

Retailers 

For more information

Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime